Radiation oncology firm Elekta has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Leksell Gamma Knife Icon intracranial radiosurgery system.
The sixth generation of Elekta's Gamma Knife system, Gamma Knife Icon features the company's online Adaptive DoseControl technology, high-definition motion management techniques, and the ability to provide frameless treatments, according to the vendor. It can also perform microradiosurgery, Elekta said.
Elekta received the European CE Mark for Gamma Knife Icon in June and deployed the first system at University Hospital La Timone in Marseille, France.
